Identification of tight junction modulating lipids

Journal of Pharmaceutical Sciences

Volumn 98, Issue 2, 2009, Pages 606-619

  Chen Quay, Shu Chih ^a   Eiting, Kristine T ^a   Li, Angela W A ^a   Lamharzi, Najib ^a   Quay, Steven C ^a  

^a Nastech Pharmaceutical Company Inc   (United States)

Author keywords

Alkylglycosides; Ceramides; Epithelial delivery permeability; Ether lipids; Glycosylated sphingosine; Lipids lipoproteins; Mucosal delivery; Nasal absorption; Oxidized lipid; Tight junction

Indexed keywords

ALKYL GROUP; CERAMIDE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLYCOSIDE; LIPID; LIPOPROTEIN; SPHINGOSINE; DEXTRAN; DRUG CARRIER; ETHER DERIVATIVE; EXCIPIENT; FLUORESCEIN DERIVATIVE; FLUORESCEIN DEXTRAN; FLUORESCEIN-DEXTRAN; MEMBRANE LIPID; UNCLASSIFIED DRUG;

AIRWAY; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ELECTRIC RESISTANCE; GLYCOSYLATION; HUMAN; HUMAN CELL; TIGHT JUNCTION; TRACHEA MUCOSA; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; EPITHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; IMPEDANCE; METABOLISM; OXIDATION REDUCTION REACTION; PERMEABILITY; RESPIRATORY TRACT MUCOSA;

CELL SURVIVAL; CELLS, CULTURED; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; ETHERS; EXCIPIENTS; FLUORESCEINS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSIDES; HUMANS; MEMBRANE LIPIDS; OXIDATION-REDUCTION; PERMEABILITY; RESPIRATORY MUCOSA; SPHINGOSINE; TIGHT JUNCTIONS;

EID: 59849113523     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21462     Document Type: Article

References (19)

1. Stevenson BR. 1998. The tight junction: Morphology to molecules. Annu Rev Cell Dev Biol 14:89-109.
2. Tsukita S, Furuse M, Itoh M. 2001. Multifunctional stands in tight junctions. Nat Rev Mol Cell Biol 2:285-293.
3. González-Mariscal L, Betanzos A, Nava P, Jaramillo BE. 2003. Tight junction proteins. Prog Biophys Mol Biol 81:1-44.
4. Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387:569-572.
5. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, Eastburn KK, Madara JL. 2000. Tight junctions are membrane microdomains. J Cell Sci 113:1771-1781.
6. Francis SA, Kelly JM, McCormack J, Rogers RA, Lai J, Schneeberger EE, Lynch RD. 1999. Rapid reduction of MDCK cell cholesterol by methyl-beta- cyclodextrin alters steady state transepithelial electrical resistance. Eur J Cell Biol 78:473-483.
7. Fromter E, Diamond J. 1972. Route of passive ion permeation in Epithelia. Nat New Biol 53:9-13.
8. Chen SC, Eiting K, Cui K, Leonard AK, Morris D, Li CY, Farber K, Sileno AP, Houston ME, Jr., Johnson PH, Quay SC, Costantino HR. 2006. Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery. J Pharm Sci 95:1364-1371.
9. Marathe GK, Davies SS, Harrison KA, Silva AR, Murphy RC, Castro-Faria-Neto H, Prescott SM, Zimmerman GA, McIntyre TM. 1999. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem 274:28395-28404.
10. Leroy A, de Bruyne GK, Oomen LC, Mareel MM. 2003. Alkylphospholipids reversibly open epithelial tight junctions. Anticancer Res 23:27-32.
11. MacDonald RC, Ashley GW, Shida MM, Rakhmanova VA, Tarahovsky YS, Pantazatos DP, Kennedy MT, Pozharski EV, Baker KA, Jones RD, Rosenzweig HS, Choi KL, Qiu R, McIntosh TJ. 1999. Physical and biological properties of cationic triesters of phosphatidylcholine. Biophys J 77:2612-2629.
12. Johnson PH, Quay SC. 2005. Advances in nasal drug delivery through tight junction technology. Expert Opin Drug Deliv 2:281-298.
13. Ahsan F, Arnold JJ, Meezan E, Pillion DJ. 2003. Sucrose cocoate, a component of cosmetic preparations, enhances nasal and ocular peptide absorption. Int J Pham 251:195-203.
14. Ensminger AH, Ensminger ME, Kolande JE, Robson JRK. 1983. Coconut oil. In: Food and Nutrition Encyclopedia, vol. 1 (A-H). Clovis: Pegasus Press. p 440.
15. Ahsan F, Arnold JJ, Yang T, Meezan E, Schwiebert EM, Pillion DJ. 2003. Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-). Eur J Pham Sci 20:27-34.
16. Johnson PH, Frank DE, Costantino HR. 2007. Discovery of tight junction modulators: Significance for drug development and delivery. Drug Discovery Today 13:261-267.
17. Lohmeyer M, Bittman R. 1994. Antitumor ether lipids and alkylphosphocholines. Drugs Future 19:1021-1037.
18. Chen SC, Eiting KT, Li W-A, Lamharzi N, Quay SC. 2005. Peptide Drug Permeation Enhancement By Select Classes Of Lipids. Presented at the 45th American Society of Cell Biology, San Francisco, CA, December 10-14.
19. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. 1995. Atherosclerosis: Basic mechanisms oxidation, inflammation, and genetics. Circulation 91:2488-2496.